SSStephen Mark Schwartz

Stephen Mark Schwartz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stephen Mark Schwartz has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Unifying Hypothesis for Scleroderma: Identifying a Target Cell for Scleroderma

    by William M. Mahoney, Jo Nadine Fleming, Stephen M. Schwartz

    We propose that a recent change in the conception of the role of type 1 interferon and the identification of adventitial stem cells suggests a unifying hypothesis for scleroderma. This hypothesis begins with vasospasm. Vasospasm is fully reversible unless, as proposed here, the resulting ischemia leads to apoptosis and activation of type 1 interferon. The interferon, we propose, initiates immune amplification, including characteristic scleroderma-specific antibodies. We propose that the interferon also acts on adventitial stem cells, producing myofibroblasts, rarefaction, and intimal hyperplasia—three morphologic changes that characterize this disease. Regulator of G-protein signaling 5 (RGS5), a regulator of vasoactive G-protein–coupled receptors, is a cell type–specific marker of pericytes and scleroderma myofibroblasts. RGS5 may provide a key link between initial hyperplasia and fibrosis in this disease.


  • Open Access

    Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma

    by Hangjun Duan, Jo Fleming, David K. Pritchard, Lynn M. Amon, Jun Xue, Heather A. Arnett, Guang Chen, Patricia Breen, Jane H. Buckner, Jerry A. Molitor, et al.

    Objective: We attempted to elucidate possible pathogenetic mechanisms in scleroderma by analysis of gene expression patterns of purified monocytes and lymphocytes, as well as protein profiles of cytokines and growth factors.Methods: Expression analysis was performed on messenger RNA (mRNA) from cells that had been purified with magnetic beads. Plasma samples from the same patients were used for multiplex cytokine analysis. Potential sources of proteins were also examined by in situ hybridization of skin specimens.Results: A total of 1,800 genes from monocytes and 863 genes from CD4+ T cells were differentially expressed in scleroderma patients. As observed by other investigators using unfractionated peripheral blood cells from patients with autoimmune connective tissue diseases, the cell type–specific analyses of our scleroderma samples showed expression of genes suggesting the presence of interferon‐α (IFNα), despite the apparent absence of this cytokine in plasma. IFNα RNA was, however, expressed at enhanced levels in vascular and perivascular cells in scleroderma skin samples. While levels of interleukin‐1α (IL‐1α) and IL‐16 were among 10 proteins found to be significantly elevated in scleroderma patients, none of the large panel of plasma cytokines we analyzed correlated with the expression levels of putative IFN response genes.Conclusion: The pattern of up‐regulation of mRNA in both the monocytes and CD4 lymphocytes of scleroderma patients, together with the detection of IFNα RNA in the microvasculature, suggests that leukocytes respond to this cytokine locally in the vessels. Detection of high levels of IL‐1α and IL‐16 in plasma and the independence of these protein levels from the IFN signature, implicates an independent contribution of other cytokines to immune activation and/or inflammation in scleroderma.


  • Open Access

    A Marfan syndrome gene expression phenotype in cultured skin fibroblasts

    by Zizhen Yao, Jochen C Jaeger, Walter L Ruzzo, Cecile Z Morale, Mary Emond, Uta Francke, Dianna M Milewicz, Stephen M Schwartz, Eileen R Mulvihill

    Background: Marfan syndrome (MFS) is a heritable connective tissue disorder caused by mutations in the fibrillin-1 gene. This syndrome constitutes a significant identifiable subtype of aortic aneurysmal disease, accounting for over 5% of ascending and thoracic aortic aneurysms. Results: We used spotted membrane DNA macroarrays to identify genes whose altered expression levels may contribute to the phenotype of the disease. Our analysis of 4132 genes identified a subset with significant expression differences between skin fibroblast cultures from unaffected controls versus cultures from affected individuals with known fibrillin-1 mutations. Subsequently, 10 genes were chosen for validation by quantitative RT-PCR. Conclusion: Differential expression of many of the validated genes was associated with MFS samples when an additional group of unaffected and MFS affected subjects were analyzed (p-value < 3 × 10-6 under the null hypothesis that expression levels in cultured fibroblasts are unaffected by MFS status). An unexpected observation was the range of individual gene expression. In unaffected control subjects, expression ranges exceeding 10 fold were seen in many of the genes selected for qRT-PCR validation. The variation in expression in the MFS affected subjects was even greater.


  • Open Access

    Plaque Rupture in Humans and Mice

    by Stephen M. Schwartz, Zorina S. Galis, Michael E. Rosenfeld, Erling Falk

    Despite the many studies of murine atherosclerosis, we do not yet know the relevance of the natural history of this model to the final events precipitated by plaque disruption of human atherosclerotic lesions. The literature has become particularly confused because of the common use of terms such as “instability”, “vulnerable”, “rupture”, or even “thrombosis” for features of plaques in murine model systems not yet shown to rupture spontaneously and in an animal surprisingly resistant to formation of thrombi at sites of atherosclerosis. We suggest that use of conclusory terms like “vulnerable” and “stable” should be discouraged. Similarly, terms such as “buried fibrous caps” that imply preceding events that are unproven tend to create confusion. We will argue that such terminology may mislead readers by implying knowledge that does not yet exist. We suggest, instead, a focus on specific processes that various forms of data have implicated in plaque progression. For example, formation of the fibrous cap, protease activation, and cell death in the necrotic core can be well described and have all been modeled in well-defined experiments. The relevance of such well-defined, objective, descriptive observations in the mouse can be tested for relevance against data from human pathology.


  • PSGL‐1 and mTOR regulate translation of ROCK‐1 and physiological functions of macrophages

    by Richard Fox, Thomas Q Nhan, G Lynn Law, David R Morris, W Conrad Liles, Stephen M Schwartz

    Rho‐associated kinases (ROCKs) are critical molecules involved in the physiological functions of macrophages, such as chemotaxis and phagocytosis. We demonstrate that macrophage adherence promotes rapid changes in physiological functions that depend on translational upregulation of preformed ROCK‐1 mRNA, but not ROCK‐2 mRNA. Before adherence, both ROCK mRNAs were present in the cytoplasm of macrophages, whereas ROCK proteins were undetectable. Macrophage adherence promoted signaling through P‐selectin glycoprotein ligand‐1 (PSGL‐1)/Akt/mTOR that resulted in synthesis of ROCK‐1, but not ROCK‐2. Following synthesis, ROCK‐1 was catalytically active. In addition, there was a rapamycin/sirolimus‐sensitive enhanced loading of ribosomes on preformed ROCK‐1 mRNAs. Inhibition of mTOR by rapamycin abolished ROCK‐1 synthesis in macrophages resulting in an inhibition of chemotaxis and phagocytosis. Macrophages from PSGL‐1‐deficient mice recapitulated pharmacological inhibitor studies. These results indicate that receptor‐mediated regulation at the level of translation is a component of a rapid set of mechanisms required to direct the macrophage phenotype upon adherence and suggest a mechanism for the immunosuppressive and anti‐inflammatory effects of rapamycin/sirolimus.


  • The p17 Cleaved Form of Caspase-3 Is Present Within Viable Macrophages In Vitro and in Atherosclerotic Plaque

    by Thomas Q. Nhan, W. Conrad Liles, Alan Chait, John T. Fallon, Stephen M. Schwartz

    Objective— In vitro studies of macrophage death in response to oxidized LDL (oxLDL) were undertaken as a model for the formation of the necrotic core of atherosclerotic plaque. Methods and Results— Thioglycollate-elicited mouse peritoneal macrophages avidly incorporated both oxLDL and acetylated LDL (acLDL) to become foam cells. oxLDL-treated macrophages, but not acLDL-treated macrophages, showed nearly 100% death, with characteristics consistent with apoptosis, including cell surface phosphatidylserine exposure, intracellular caspase-3 activity, cleavage of caspase-3 substrates, and DNA fragmentation, as shown by TUNEL assay. The activated form of caspase-3 (p17 cleaved form) was present in attached, viable macrophages before exposure to oxLDL. This p17 form was also found in apparently viable as well as in TUNEL-positive cells within atherosclerotic lesions of chow-fed apolipoprotein E–deficient (ApoE −/− ) mice. The amount of p17 caspase-3 was reduced by in vitro blockade of FasL with an FasL-blocking antibody and was absent in macrophages from lpr/lpr mice, which lack functional Fas. Moreover, lpr/lpr macrophages resisted oxLDL cytotoxicity. Conclusions— The naturally occurring Fas-FasL induction of caspase-3 cleavage after macrophage attachment may represent an important physiologic mechanism that primes for cytotoxicity by oxLDL and possibly, other death-inducing molecules.


  • Application of Biologic Skepticism to Analysis of Expression Phenotypes

    by Lawrence Adams, Roger E. Bumgarner, Stephen Mark Schwartz

  • An Update of the Grützbalgϕ Hypothesis: The Role of Thrombosis and Coagulation in Atherosclerotic Progression

    by Karen O. Yee, Yuji Ikari, Stephen M. Schwartz

    Summary: While a great deal has been learned about the initiation of atherosclerosis, much less is known about the factors that ultimately determine progression and clinical manifestations. In this review we will focus on the possible role of coagulation, especially intramural fibrin in lesion progression.


  • Proliferation and the Monoclonal Origins of Atherosclerotic Lesions

    by S.M. Schwartz, C.E. Murry, Md, Ph D

    Benditt's observation of the monoclonal origin of the atherosclerotic lesion has been controversial because it appeared to conflict with conventional wisdom. A new method based on a polymerase chain reaction amplification of the DNA of an X-inactivated gene from microdissected tissue confirms that Benditt was correct. However, this monoclonal expansion can also be found in nonatherosclerotic intima and media. These new data suggest that plaque clonality may represent expansion of preexisting patches of cells arising during development of the media. This developmental view does not conflict with other recent evidence that plaque expansion is associated with mutation or viral events. However, if plaques arise from patches, then early developmental mechanisms may be critical to the later evolution of the lesions.